This Article Abstract Free Full Text (Free PDF) Free Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in Web of Science Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via HighWire Citing Articles via Web of Science (10) Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Villmann, C. Articles by Becker, C.-M. Search for Related Content PubMed PubMed Citation Articles by Villmann, C. Articles by Becker, C.-M. Pubmed/NCBI databases Medline Plus Health Information Degenerative Nerve Diseases Social Bookmarking                         What's this?

On the Hypes and Falls in Neuroprotection: Targeting the NMDA Receptor

Institut für Biochemie, Emil-Fischer-Zentrum Universität Erlangen-Nürnberg

Cord-Michael Becker

Institut für Biochemie, Emil-Fischer-Zentrum Universität Erlangen-Nürnberg, cmb{at}biochem.uni-erlangen.de

Activation of the NMDA (N-methyl-D-aspartate) responsive subclass of glutamate receptors is an important mechanism of excitatory synaptic transmission. Moreover, NMDA receptors are widely involved in many forms of synaptic plasticity such as long-term potentiation (LTP) and long-term depression (LTD), which are thought to underlie complex tasks, including learning and memory. Dysfunction of these ligand-gated cation channels has been identified as an underlying molecular mechanism in neurological disorders ranging from acute stroke to chronic neurodegeneration in amyotrophic lateral sclerosis. Excessive glutamate levels have been detected following brain trauma and cerebral ischemia, resulting in an unregulated stimulation of NMDA receptors. These conditions are thought to elicit a cascade of excitation-mediated neuronal damage where massive increases in intracellular calcium concentrations finally trigger neuronal damage and apoptosis. Consistent with the hypothesis of NMDA receptors as essential mediators of excitotoxicity, the different functional domains of these ion channels have been identified as potential targets for neuroprotective agents. Following an initial hype on potential NMDA receptor therapeutics, the authors currently see a period of skepticism that, in reverse, appears to neglect the therapeutic potential of this receptor class. This review attempts a reappraisal of this important class of neurotransmitter receptors, with a focus on NMDA receptor heterogeneity, ligand binding domains, and candidate diseases for a potential neuroprotective therapy. NEUROSCIENTIST 13(6):594—615, 2007. DOI: 10.1177/1073858406296259

Key Words: NMDA receptors • Excitotoxicity • Synaptic plasticity • Neuroprotection • Drug targets • CNS disorders • Neurodegeneration

References

• Aizenman E. 1994. Redox modulation of the NMDA receptor. In: Palfreyman MG, Reynolds IJ, Skolnik P, editors. Direct and allosteric control of glutamate receptors. Boca Raton, FL: CRC Press, p 95—104.
• Albers GW, Clark WM, Atkinson RP, Madden K., Data JL, Whitehouse MJ 1999. Dose escalation study of the NMDA glycine-site antagonist licostinel in acute ischemic stroke. Stroke 30:508—13.[Medline] [Order article via Infotrieve]
• Antzoulatos EG, Byrne JH 2004. Learning insights transmitted by glutamate. Trends Neurosci 27:555—60.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• Arden SR, Sinor JD, Potthoff WK, Aizenman E. 1998. Subunit-specific interactions of cyanide with the N-methyl-D-aspartate receptor. J Biol Chem 273:21505—11.[Abstract/Free Full Text]
• Armstrong N., Gouaux E. 2000. Mechanisms for activation and antagonism of an AMPA-sensitive glutamate receptor: crystal structures of the GluR2 ligand binding core. Neuron 28:165—81.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• Armstrong N., Sun Y., Chen GQ, Gouaux E. 1998. Structure of a glutamate-receptor ligand-binding core in complex with kainate. Nature 395:913—7.[CrossRef][Medline] [Order article via Infotrieve]
• Arvidsson A., Kokaia Z., Lindvall O. 2001. N-methyl-D-aspartate receptor-mediated increase of neurogenesis in adult rat dentate gyrus following stroke. Eur J Neurosci 14:10—8.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• Ayalon G., Stern-Bach Y. 2001. Functional assembly of AMPA and kainate receptors is mediated by several discrete protein-protein interactions. Neuron 31:103—13.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• Banke TG, Traynelis SF 2003. Activation of NR1/NR2B NMDA receptors. Nat Neurosci 6:144—52.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• Barria A., Derkach V., Soderling T. 1997. Identification of the Ca2+/calmodulin-dependent protein kinase II regulatory phosphorylation site in the alpha-amino-3-hydroxyl-5-methyl-4-isoxazole-propionate-type glutamate receptor. J Biol Chem 272:32727—30.[Abstract/Free Full Text]
• Barria A., Malinow R. 2005. NMDA receptor subunit composition controls synaptic plasticity by regulating binding to CaMKII. Neuron 48:289—301.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• Bayer KU, De Koninck P., Leonard AS, Hell JW, Schulman H. 2001. Interaction with the NMDA receptor locks CaMKII in an active conformation. Nature 411:801—5.[CrossRef][Medline] [Order article via Infotrieve]
• Becker CM 1999. Neurotransmitter receptors as potential targets of glaucoma pathogens. In: Gramer E, Grehn F, editors. Pathogenesis and risk factors of glaucoma. Berlin: Springer-Verlag.
• Ben-Abraham R., Weinbroum AA 2000. Dextromethorphan in chronic pain: a disappointing update. Isr Med Assoc J 2:708—10.[Web of Science][Medline] [Order article via Infotrieve]
• Bennett MV, Pellegrini-Giampietro DE, Gorter JA, Aronica E., Connor JA, Zukin RS 1996. The GluR2 hypothesis: Ca(++)-permeable AMPA receptors in delayed neurodegeneration. Cold Spring Harb Symp Quant Biol 61:373—84.[Abstract/Free Full Text]
• Berberich S., Punnakkal P., Jensen V., Pawlak V., Seeburg PH, Hvalby O., and others. 2005. Lack of NMDA receptor subtype selectivity for hippocampal long-term potentiation. J Neurosci 25:6907—10.[Abstract/Free Full Text]
• Bramlett HM, Dietrich WD 2004. Pathophysiology of cerebral ischemia and brain trauma: similarities and differences. J Cereb Blood Flow Metab 24:133—50.[Web of Science][Medline] [Order article via Infotrieve]
• Brandt C., Potschka H., Loscher W., Ebert U. 2003. N-methyl-D-aspartate receptor blockade after status epilepticus protects against limbic brain damage but not against epilepsy in the kainate model of temporal lobe epilepsy. Neuroscience 118:727—40.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• Brickley SG, Misra C., Mok MH, Mishina M., Cull-Candy SG 2003. NR2B and NR2D subunits coassemble in cerebellar Golgi cells to form a distinct NMDA receptor subtype restricted to extrasynaptic sites. J Neurosci 23:4958—66.[Abstract/Free Full Text]
• Brimecombe JC, Boeckman FA, Aizenman E. 1997. Functional consequences of NR2 subunit composition in single recombinant N-methyl-D-aspartate receptors. Proc Natl Acad Sci USA 94:11019—24.[Abstract/Free Full Text]
• Brimecombe JC, Gallagher MJ, Lynch DR, Aizenman E. 1998. An NR2B point mutation affecting haloperidol and CP101,606 sensitivity of single recombinant N-methyl-D-aspartate receptors. J Pharmacol Exp Ther 286:627—34.[Abstract/Free Full Text]
• Burnashev N., Schoepfer R., Monyer H., Ruppersberg JP, Gunther W., Seeburg PH, and others. 1992. Control by asparagine residues of calcium permeability and magnesium blockade in the NMDA receptor. Science 257:1415—9.[Abstract/Free Full Text]
• Burnashev N., Villarroel A., Sakmann B. 1996. Dimensions and ion selectivity of recombinant AMPA and kainate receptor channels and their dependence on Q/R site residues. J Physiol 496(Pt 1):165—73.[Abstract/Free Full Text]
• Burnashev N., Zhou Z., Neher E., Sakmann B. 1995. Fractional calcium currents through recombinant GluR channels of the NMDA, AMPA and kainate receptor subtypes. J Physiol 485(Pt 2): 403—18.[Abstract/Free Full Text]
• Castellani GC, Quinlan EM, Cooper LN, Shouval HZ 2001. A biophysical model of bidirectional synaptic plasticity: dependence on AMPA and NMDA receptors. Proc Natl Acad Sci USA 98:12772—7.[Abstract/Free Full Text]
• Cathala L., Misra C., Cull-Candy S. 2000. Developmental profile of the changing properties of NMDA receptors at cerebellar mossy fiber-granule cell synapses. J Neurosci 20:5899—905.[Abstract/Free Full Text]
• Charton JP, Herkert M., Becker CM, Schroder H. 1999. Cellular and subcellular localization of the 2B-subunit of the NMDA receptor in the adult rat telencephalon. Brain Res 816:609—17.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• Chatterton JE, Awobuluyi M., Premkumar LS, Takahashi H., Talantova M., Shin Y., and others. 2002. Excitatory glycine receptors containing the NR3 family of NMDA receptor subunits. Nature 415:793—8.[Medline] [Order article via Infotrieve]
• Chazot PL, Lawrence S., Thompson CL 2002. Studies on the subtype selectivity of CP-101,606: evidence for two classes of NR2B-selective NMDA receptor antagonists. Neuropharmacology 42:319—24.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• Chen GQ, Cui C., Mayer ML, Gouaux E. 1999. Functional characterization of a potassium-selective prokaryotic glutamate receptor. Nature 402:817—21.[CrossRef][Medline] [Order article via Infotrieve]
• Chen HS, Lipton SA 1997. Mechanism of memantine block of NMDA-activated channels in rat retinal ganglion cells: uncompetitive antagonism. J Physiol 499(Pt 1):27—46.[Abstract/Free Full Text]
• Chen HS, Lipton SA 2005. Pharmacological implications of two distinct mechanisms of interaction of memantine with N-methyl-D-aspartate-gated channels. J Pharmacol Exp Ther 314:961—71.[Abstract/Free Full Text]
• Chen N., Moshaver A., Raymond LA 1997. Differential sensitivity of recombinant N-methyl-D-aspartate receptor subtypes to zinc inhibition. Mol Pharmacol 51:1015—23.[Abstract/Free Full Text]
• Chittajallu R., Braithwaite SP, Clarke VR, Henley JM 1999. Kainate receptors: subunits, synaptic localization and function. Trends Pharmacol Sci 20:26—35.[CrossRef][Medline] [Order article via Infotrieve]
• Choi YB, Lipton SA 1999. Identification and mechanism of action of two histidine residues underlying high-affinity Zn2+ inhibition of the NMDA receptor. Neuron 23:171—80.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• Chung HJ, Huang YH, Lau LF, Huganir RL 2004. Regulation of the NMDA receptor complex and trafficking by activity-dependent phosphorylation of the NR2B subunit PDZ ligand. J Neurosci 24:10248—59.[Abstract/Free Full Text]
• Ciabarra AM, Sullivan JM, Gahn LG, Pecht G., Heinemann S., Sevarino KA 1995. Cloning and characterization of chi-1: a developmentally regulated member of a novel class of the ionotropic glutamate receptor family. J Neurosci 15:6498—508.[Abstract/Free Full Text]
• Clausen T., Bullock R. 2001. Medical treatment and neuroprotection in traumatic brain injury. Curr Pharm Des 7:1517—32.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• Colonnese MT, Zhao JP, Constantine-Paton M. 2005. NMDA receptor currents suppress synapse formation on sprouting axons in vivo. J Neurosci 25:1291—1303.[Abstract/Free Full Text]
• Das S., Sasaki YF, Rothe T., Premkumar LS, Takasu M., Crandall JE, and others. 1998. Increased NMDA current and spine density in mice lacking the NMDA receptor subunit NR3A. Nature 393:377—81.[CrossRef][Medline] [Order article via Infotrieve]
• Davis SM, Lees KR, Albers GW, Diener HC, Markabi S., Karlsson G., and others. 2000. Selfotel in acute ischemic stroke: possible neurotoxic effects of an NMDA antagonist. Stroke 31:347—54.[Abstract/Free Full Text]
• Dildy-Mayfield JE, Leslie SW 1991. Mechanism of inhibition of N-methyl-D-aspartate-stimulated increases in free intracellular Ca2+ concentration by ethanol. J Neurochem 56:1536—43.[Web of Science][Medline] [Order article via Infotrieve]
• Dingledine R., Borges K., Bowie D., Traynelis SF 1999. The glutamate receptor ion channels. Pharmacol Rev 51:7—61.[Abstract/Free Full Text]
• Dorr J., Roth K., Zurbuchen U., Deisz R., Bechmann I., Lehmann TN, and others. 2005. Tumor-necrosis-factor-related apoptosis-inducing-ligand (TRAIL)—mediated death of neurons in living human brain tissue is inhibited by flupirtine-maleate. J Neuroimmunol 167:204—9.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• Ehlers MD, Zhang S., Bernhadt JP, Huganir RL 1996. Inactivation of NMDA receptors by direct interaction of calmodulin with the NR1 subunit. Cell 84:745—55.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• Erreger K., Traynelis SF 2005. Allosteric interaction between zinc and glutamate binding domains on NR2A causes desensitization of NMDA receptors. J Physiol 569:381—93.[Abstract/Free Full Text]
• Falk WE, Daly EJ, Tsai GE, Gunther J., Brown P. 2002. A case series of D-cycloserine added to donepezil in the treatment of Alzheimer's disease. J Neuropsychiatry Clin Neurosci 14:466—7.[Free Full Text]
• Farin A., Marshall LF 2004. Lessons from epidemiologic studies in clinical trials of traumatic brain injury. Acta Neurochir Suppl 89:101—7.[Medline] [Order article via Infotrieve]
• Fiskum G., Starkov A., Polster BM, Chinopoulos C. 2003. Mitochondrial mechanisms of neural cell death and neuroprotective interventions in Parkinson's disease. Ann N Y Acad Sci 991:111—9.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• Francis PT 2003. Glutamatergic systems in Alzheimer's disease. Int J Geriatr Psychiatry 18:S15—21.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• Furukawa H., Gouaux E. 2003. Mechanisms of activation, inhibition and specificity: crystal structures of the NMDA receptor NR1 ligand-binding core. Embo J 22:2873—85.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• Furukawa H., Singh SK, Mancusso R., Gouaux E. 2005. Subunit arrangement and function in NMDA receptors. Nature 438:185—92.[CrossRef][Medline] [Order article via Infotrieve]
• Garaschuk O., Schneggenburger R., Schirra C., Tempia F., Konnerth A. 1996. Fractional Ca2+ currents through somatic and dendritic glutamate receptor channels of rat hippocampal CA1 pyramidal neurones. J Physiol 491(Pt 3):757—72.[Abstract/Free Full Text]
• Gass P., Muelhardt C., Sommer C., Becker CM, Kiessling M. 1993. NMDA and glycine receptor mRNA expression following transient global ischemia in the gerbil brain. J Cereb Blood Flow Metab 13:337—41.[Web of Science][Medline] [Order article via Infotrieve]
• Gibb AJ 2004. NMDA receptor subunit gating—uncovered. Trends Neurosci 27:7—10; discussion 10.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• Gill R., Alanine A., Bourson A., Buttelmann B., Fischer G., Heitz MP, and others. 2002. Pharmacological characterization of Ro 63-1908 (1-[2-(4-hydroxy-phenoxy)-ethyl]-4-(4-methyl-benzyl)-piperidin-4-ol), a novel subtype-selective N-methyl-D-aspartate antagonist. J Pharmacol Exp Ther 302:940—8.
• Gladstone DJ, Black SE, Hakim AM 2002. Toward wisdom from failure: lessons from neuroprotective stroke trials and new therapeutic directions. Stroke 33:2123—36.[Abstract/Free Full Text]
• Goff DC, Coyle JT 2001. The emerging role of glutamate in the pathophysiology and treatment of schizophrenia. Am J Psychiatry 158:1367—77.[Abstract/Free Full Text]
• Goff DC, Tsai G., Manoach DS, Flood J., Darby DG, Coyle JT 1996. D-cycloserine added to clozapine for patients with schizophrenia. Am J Psychiatry 153:1628—30.[Abstract/Free Full Text]
• Gonzales RA, Woodward JJ 1990. Ethanol inhibits N-methyl-D-aspartate-stimulated [3H]norepinephrine release from rat cortical slices. J Pharmacol Exp Ther 253:1138—44.[Abstract/Free Full Text]
• Halpern DL, Grosskreutz CL 2002. Glaucomatous optic neuropathy: mechanisms of disease. Ophthalmol Clin North Am 15:61—8.
• Hatton CJ, Paoletti P. 2005. Modulation of triheteromeric NMDA receptors by N-terminal domain ligands. Neuron 46:261—74.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• Hawkins LM, Prybylowski K., Chang K., Moussan C., Stephenson FA, Wenthold RJ 2004. Export from the endoplasmic reticulum of assembled N-methyl-d-aspartic acid receptors is controlled by a motif in the c terminus of the NR2 subunit. J Biol Chem 279:28903—10.[Abstract/Free Full Text]
• Herb A., Burnashev N., Werner P., Sakmann B., Wisden W., Seeburg PH 1992. The KA-2 subunit of excitatory amino acid receptors shows widespread expression in brain and forms ion channels with distantly related subunits. Neuron 8:775—85.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• Herin GA, Aizenman E. 2004. Amino terminal domain regulation of NMDA receptor function. Eur J Pharmacol 500:101—11.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• Herkert M., Rottger S., Becker CM 1998. The NMDA receptor subunit NR2B of neonatal rat brain: complex formation and enrichment in axonal growth cones. Eur J Neurosci 10:1553—62.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• Herrero JF, Laird JM, Lopez-Garcia JA 2000. Wind-up of spinal cord neurones and pain sensation: much ado about something? Prog Neurobiol 61:169—203.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• Hof PR, Lee PY, Yeung G., Wang RF, Podos SM, Morrison JH 1998. Glutamate receptor subunit GluR2 and NMDAR1 immunoreactivity in the retina of macaque monkeys with experimental glaucoma does not identify vulnerable neurons. Exp Neurol 153:234—41. Holcomb HH, Lahti AC, Medoff DR, Cullen T., Tamminga CA 2005. Effects of noncompetitive NMDA receptor blockade on anterior cingulate cerebral blood flow in volunteers with schizophrenia. Neuropsychopharmacology 30:2275—82.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• Hollmann M., Boulter J., Maron C., Beasley L., Sullivan J., Pecht G., and others. 1993. Zinc potentiates agonist-induced currents at certain splice variants of the NMDA receptor. Neuron 10:943—54.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• Hollmann M., Heinemann S. 1994. Cloned glutamate receptors. Annu Rev Neurosci 17:31—108.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• Holmes KD, Mattar PA, Marsh DR, Weaver LC, Dekaban GA 2002. The N-methyl-D-aspartate receptor splice variant NR1-4 C-terminal domain: deletion analysis and role in subcellular distribution. J Biol Chem 277:1457—68.[Abstract/Free Full Text]
• Honack D., Loscher W. 1995. Kindling increases the sensitivity of rats to adverse effects of certain antiepileptic drugs. Epilepsia 36:763—71. Horning MS, Mayer ML 2004. Regulation of AMPA receptor gating by ligand binding core dimers. Neuron 41:379—88.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• Hoyte L., Barber PA, Buchan AM, Hill MD 2004. The rise and fall of NMDA antagonists for ischemic stroke. Curr Mol Med 4:131—6.[CrossRef]
• Ichinose T., Yu S., Wang XQ, Yu SP 2003. Ca2+-independent, but voltage-and activity-dependent regulation of the NMDA receptor outward K+ current in mouse cortical neurons. J Physiol 551:403—17.[Abstract/Free Full Text]
• Ikonomidou C., Stefovska V., Turski L. 2000. Neuronal death enhanced by N-methyl-D-aspartate antagonists. Proc Natl Acad Sci USA 97:12885—90.[Abstract/Free Full Text]
• Ikonomidou C., Turski L. 1996. Prevention of trauma-induced neurodegeneration in infant and adult rat brain: glutamate antagonists. Metab Brain Dis 11:125—41.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• Ikonomidou C., Turski L. 2002. Why did NMDA receptor antagonists fail clinical trials for stroke and traumatic brain injury? Lancet Neurol 1:383—86.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• Inanobe A., Furukawa H., Gouaux E. 2005. Mechanism of partial agonist action at the NR1 subunit of NMDA receptors. Neuron 47:71—84.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• Itil T., Keskiner A., Kiremitci N., Holden JM 1967. Effect of phencyclidine in chronic schizophrenics. Can Psychiatr Assoc J 12:209—12.[Web of Science][Medline] [Order article via Infotrieve]
• Ivanovic A., Reilander H., Laube B., Kuhse J. 1998. Expression and initial characterization of a soluble glycine binding domain of the N-methyl-D-aspartate receptor NR1 subunit. J Biol Chem 273:19933—7.[Abstract/Free Full Text]
• Javitt DC 1999. Treatment of negative and cognitive symptoms. Curr Psychiatry Rep 1:25—30.[Medline] [Order article via Infotrieve]
• Javitt DC, Zukin SR 1989. Interaction of [3H]MK-801 with multiple states of the N-methyl-D-aspartate receptor complex of rat brain. Proc Natl Acad Sci USA 86:740—4.[Abstract/Free Full Text]
• Javitt DC, Zukin SR 1991. Recent advances in the phencyclidine model of schizophrenia. Am J Psychiatry 148:1301—8.[Abstract/Free Full Text]
• Jia Z., Agopyan N., Miu P., Xiong Z., Henderson J., Gerlai R., and others. 1996. Enhanced LTP in mice deficient in the AMPA receptor GluR2. Neuron 17:945—56.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• Jones KS, VanDongen HM, VanDongen AM 2002. The NMDA receptor M3 segment is a conserved transduction element coupling ligand binding to channel opening. J Neurosci 22:2044—53.[Abstract/Free Full Text]
• Kalloniatis M., Sun D., Foster L., Haverkamp S., Wassle H. 2004. Localization of NMDA receptor subunits and mapping NMDA drive within the mammalian retina. Vis Neurosci 21:587—97.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• Kellendonk C., Simpson EH, Polan HJ, Malleret G., Vronskaya S., Winiger V., and others. 2006. Transient and selective overexpression of dopamine D2 receptors in the striatum causes persistent abnormalities in prefrontal cortex functioning. Neuron 49:603—15.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• Kemp JA, McKernan RM 2002. NMDA receptor pathways as drug targets. Nat Neurosci 5(Suppl):1039—42.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• Kerrigan LA, Zack DJ, Quigley HA, Smith SD, Pease ME 1997. TUNEL-positive ganglion cells in human primary open-angle glaucoma. Arch Ophthalmol 115:1031—5.[Abstract/Free Full Text]
• Kinarsky L., Feng B., Skifter DA, Morley RM, Sherman S., Jane DE, and others. 2005. Identification of subunit- and antagonist-specific amino acid residues in the N-methyl-D-aspartate receptor glutamate-binding pocket. J Pharmacol Exp Ther 313:1066—74.[Abstract/Free Full Text]
• Kohda K., Kamiya Y., Matsuda S., Kato K., Umemori H., Yuzaki M. 2003. Heteromer formation of delta2 glutamate receptors with AMPA or kainate receptors. Brain Res Mol Brain Res 110:27—37.[Medline] [Order article via Infotrieve]
• Kriz J., Gowing G., Julien JP 2003. Efficient three-drug cocktail for disease induced by mutant superoxide dismutase. Ann Neurol 53:429—36.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• Krupp JJ, Vissel B., Heinemann SF, Westbrook GL 1998, N-terminal domains in the NR2 subunit control desensitization of NMDA receptors. Neuron 20:317—27.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• Kunishima N., Shimada Y., Tsuji Y., Sato T., Yamamoto M., Kumasaka T., and others. 2000. Structural basis of glutamate recognition by a dimeric metabotropic glutamate receptor. Nature 407:971—7.[CrossRef][Medline] [Order article via Infotrieve]
• Kuusinen A., Abele R., Madden DR, Keinanen K. 1999. Oligomerization and ligand-binding properties of the ectodomain of the alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionic acid receptor subunit GluRD. J Biol Chem 274:28937—43.[Abstract/Free Full Text]
• Kuusinen A., Arvola M., Keinanen K. 1995. Molecular dissection of the agonist binding site of an AMPA receptor. Embo J 14:6327—32.[Web of Science][Medline] [Order article via Infotrieve]
• Laake K., Oeksengaard AR 2002. D-cycloserine for Alzheimer's disease. Cochrane Database Syst Rev (2):CD003153.
• Lee HK, Takamiya K., Han JS, Man H., Kim CH, Rumbaugh G., and others. 2003. Phosphorylation of the AMPA receptor GluR1 subunit is required for synaptic plasticity and retention of spatial memory. Cell 112:631—43.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• Leker RR, Shohami E. 2002. Cerebral ischemia and trauma-different etiologies yet similar mechanisms: neuroprotective opportunities. Brain Res Brain Res Rev 39:55—73.[CrossRef][Medline] [Order article via Infotrieve]
• Leuschner WD, Hoch W. 1999. Subtype-specific assembly of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionic acid receptor subunits is mediated by their n-terminal domains. J Biol Chem 274:16907—16.[Abstract/Free Full Text]
• Liao D., Scannevin RH, Huganir R. 2001. Activation of silent synapses by rapid activity-dependent synaptic recruitment of AMPA receptors. J Neurosci 21:6008—17.[Abstract/Free Full Text]
• Lin SY, Wu K., Levine ES, Mount HT, Suen PC, Black IB 1998. BDNF acutely increases tyrosine phosphorylation of the NMDA receptor subunit 2B in cortical and hippocampal postsynaptic densities. Brain Res Mol Brain Res 55:20—7.[Medline] [Order article via Infotrieve]
• Lipton SA 2004. Paradigm shift in NMDA receptor antagonist drug development: molecular mechanism of uncompetitive inhibition by memantine in the treatment of Alzheimer's disease and other neurologic disorders. J Alzheimers Dis 6:S61—74.[Web of Science][Medline] [Order article via Infotrieve]
• Lipton SA 2005. The molecular basis of memantine action in Alzheimer's disease and other neurologic disorders: low-affinity, uncompetitive antagonism. Curr Alzheimer Res 2:155—65.[CrossRef][Medline] [Order article via Infotrieve]
• Liu L., Wong TP, Pozza MF, Lingenhoehl K., Wang Y., Sheng M., and others. 2004. Role of NMDA receptor subtypes in governing the direction of hippocampal synaptic plasticity. Science 304:1021—4.[Abstract/Free Full Text]
• LoGrasso P., McKelvy J. 2003. Advances in pain therapeutics. Curr Opin Chem Biol 7:452—6.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• Low CM, Lyuboslavsky P., French A., Le P., Wyatte K., Thiel WH, and others. 2003. Molecular determinants of proton-sensitive N-methyl-D-aspartate receptor gating. Mol Pharmacol 63:1212—22.[Abstract/Free Full Text]
• Lu W., Man H., Ju W., Trimble WS, MacDonald JF, Wang YT 2001. Activation of synaptic NMDA receptors induces membrane insertion of new AMPA receptors and LTP in cultured hippocampal neurons. Neuron 29:243—54.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• Luby ED, Cohen BD, Rosenbaum G., Gottlieb JS, Kelley R. 1959. Study of a new schizophrenomimetic drug; sernyl. AMA Arch Neurol Psychiatry 81:363—9.[Medline] [Order article via Infotrieve]
• Luo J., Wang Y., Yasuda RP, Dunah AW, Wolfe BB 1997. The majority of N-methyl-D-aspartate receptor complexes in adult rat cerebral cortex contain at least three different subunits (NR1/NR2A/NR2B). Mol Pharmacol 51:79—86.[Abstract/Free Full Text]
• Lynch DR, Guttmann RP 2002. Excitotoxicity: perspectives based on N-methyl-D-aspartate receptor subtypes. J Pharmacol Exp Ther 300:717—23.[Abstract/Free Full Text]
• Madden DR 2002. The inner workings of the AMPA receptors. Curr Opin Drug Discov Devel 5:741—8.[Web of Science][Medline] [Order article via Infotrieve]
• Malenka RC, Nicoll RA 1999. Long-term potentiation—a decade of progress? Science 285:1870—4.[Abstract/Free Full Text]
• Malmberg AB, Gilbert H., McCabe RT, Basbaum AI 2003. Powerful antinociceptive effects of the cone snail venom-derived subtype-selective NMDA receptor antagonists conantokins G and T. Pain 101:109—16.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• Martin KR, Levkovitch-Verbin H., Valenta D., Baumrind L., Pease ME, Quigley HA 2002. Retinal glutamate transporter changes in experimental glaucoma and after optic nerve transection in the rat. Invest Ophthalmol Vis Sci 43:2236—43.[Abstract/Free Full Text]
• Masuko T., Kashiwagi K., Kuno T., Nguyen ND, Pahk AJ, Fukuchi J., and others. 1999. A regulatory domain (R1-R2) in the amino terminus of the N-methyl-D-aspartate receptor: effects of spermine, protons, and ifenprodil, and structural similarity to bacterial leucine/isoleucine/valine binding protein. Mol Pharmacol 55:957—69.[Abstract/Free Full Text]
• Matsuda K., Fletcher M., Kamiya Y., Yuzaki M. 2003. Specific assembly with the NMDA receptor 3B subunit controls surface expression and calcium permeability of NMDA receptors. J Neurosci 23:10064—73.[Abstract/Free Full Text]
• Matsuda K., Kamiya Y., Matsuda S., Yuzaki M. 2002. Cloning and characterization of a novel NMDA receptor subunit NR3B: a dominant subunit that reduces calcium permeability. Brain Res Mol Brain Res 100:43—52.[Medline] [Order article via Infotrieve]
• Mayer ML 2005. Crystal structures of the GluR5 and GluR6 ligand binding cores: molecular mechanisms underlying kainate receptor selectivity. Neuron 45:539—52.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• McBain CJ, Mayer ML 1994. N-methyl-D-aspartic acid receptor structure and function. Physiol Rev 74:723—60.[Free Full Text]
• McFeeters RL, Oswald RE 2004. Emerging structural explanations of ionotropic glutamate receptor function. Faseb J 18:428—38.[Abstract/Free Full Text]
• McGeer EG, McGeer PL 2005. Pharmacologic approaches to the treatment of amyotrophic lateral sclerosis. BioDrugs 19:31—7.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• McIlhinney RA, Philipps E., Le Bourdelles B., Grimwood S., Wafford K., Sandhu S., and others. 2003. Assembly of N-methyl-D-aspartate (NMDA) receptors. Biochem Soc Trans 31:865—8.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• Meddows E., Le Bourdelles B., Grimwood S., Wafford K., Sandhu S., Whiting P., and others. 2001. Identification of molecular determinants that are important in the assembly of N-methyl-D-aspartate receptors. J Biol Chem 276:18795—803.[Abstract/Free Full Text]
• Melzer D., Ely M., Brayne C. 1997. Local population differences and the needs of people with cognitive impairment. Int J Geriatr Psychiatry 12:883—7.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• Merrill MA, Chen Y., Strack S., Hell JW 2005. Activity-driven postsynaptic translocation of CaMKII. Trends Pharmacol Sci 26:645—53.[CrossRef][Medline] [Order article via Infotrieve]
• Miki K., Zhou QQ, Guo W., Guan Y., Terayama R., Dubner R., and others. 2002. Changes in gene expression and neuronal phenotype in brain stem pain modulatory circuitry after inflammation. J Neurophysiol 87:750—60.[Abstract/Free Full Text]
• Mishizen A., Ikonomovic MD 2001. Glutamate receptors in aging and Alzheimer's disease. In: Mobbs C, Hof P, editors. Functional neurobiology of aging. New York: Academic Press, p 283—314.
• Mishizen-Eberz AJ, Rissman RA, Carter TL, Ikonomovic MD, Wolfe BB, Armstrong DM 2004. Biochemical and molecular studies of NMDA receptor subunits NR1/2A/2B in hippocampal subregions throughout progression of Alzheimer's disease pathology. Neurobiol Dis 15:80—92.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• Monyer H., Burnashev N., Laurie DJ, Sakmann B., Seeburg PH 1994. Developmental and regional expression in the rat brain and functional properties of four NMDA receptors. Neuron 12:529—40.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• Monyer H., Sprengel R., Schoepfer R., Herb A., Higuchi M., Lomeli H., and others. 1992. Heteromeric NMDA receptors: molecular and functional distinction of subtypes. Science 256:1217—21.[Abstract/Free Full Text]
• Moriyoshi K., Masu M., Ishii T., Shigemoto R., Mizuno N., Nakanishi S. 1991. Molecular cloning and characterization of the rat NMDA receptor. Nature 354:31—7.[CrossRef][Medline] [Order article via Infotrieve]
• Morris GF, Bullock R., Marshall SB, Marmarou A., Maas A., Marshall LF 1999. Failure of the competitive N-methyl-D-aspartate antagonist Selfotel (CGS 19755) in the treatment of severe head injury: results of two phase III clinical trials. The Selfotel Investigators. J Neurosurg 91:737—43.[Web of Science][Medline] [Order article via Infotrieve]
• Mothet JP, Parent AT, Wolosker H., Brady RO Jr, Linden DJ, Ferris CD, and others. 2000. D-serine is an endogenous ligand for the glycine site of the N-methyl-D-aspartate receptor. Proc Natl Acad Sci USA 97:4926—31.[Abstract/Free Full Text]
• Mott DD, Doherty JJ, Zhang S., Washburn MS, Fendley MJ, Lyuboslavsky P., and others. 1998. Phenylethanolamines inhibit NMDA receptors by enhancing proton inhibition. Nat Neurosci 1:659—67.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• Muller WE, Pergande G., Ushijima H., Schleger C., Kelve M., Perovic S. 1996. Neurotoxicity in rat cortical cells caused by N-methyl-D-aspartate (NMDA) and gp120 of HIV-1: induction and pharmacological intervention. Prog Mol Subcell Biol 16:44—57.[Medline] [Order article via Infotrieve]
• Munoz-Ruiz P., Rubio L., Garcia-Palomero E., Dorronsoro I., del Monte-Millan M., Valenzuela R., and others. 2005. Design, synthesis, and biological evaluation of dual binding site acetylcholinesterase inhibitors: new disease-modifying agents for Alzheimer's disease. J Med Chem 48:7223—33.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• Nakanishi S., Masu M. 1994. Molecular diversity and functions of glutamate receptors. Annu Rev Biophys Biomol Struct 23:319—48.[Web of Science][Medline] [Order article via Infotrieve]
• Naur P., Vestergaard B., Skov LK, Egebjerg J., Gajhede M., Kastrup JS 2005. Crystal structure of the kainate receptor GluR5 ligand-binding core in complex with (S)-glutamate. FEBS Lett 579:1154—60.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• Nicholls DG, Budd SL 2000. Mitochondria and neuronal survival. Physiol Rev 80:315—60.[Abstract/Free Full Text]
• Nishi M., Hinds H., Lu HP, Kawata M., Hayashi Y. 2001. Motoneuron-specific expression of NR3B, a novel NMDA-type glutamate receptor subunit that works in a dominant-negative manner. J Neurosci 21:RC185.[Abstract/Free Full Text]
• Omae T., Hasegawa Y., Ogata J., Tamaki K., Minematsu K., Yamaguchi T. 1996. The competitive NMDA antagonist, CGS-19755, improves postischemic hypoperfusion in selectively vulnerable regions in gerbils. J Neurol Sci 138:105—13.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• Ortega A., Eshhar N., Teichberg VI 1991. Properties of kainate receptor/channels on cultured Bergmann glia. Neuroscience 41:335—49.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• Osborne NN, Cazevieille C., Wood JP, Nash MS, Pergande G., Block F., and others. 1998. Flupirtine, a nonopioid centrally acting analgesic, acts as an NMDA antagonist. Gen Pharmacol 30:255—63.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• Osborne NN, Chidlow G., Wood JP 2006. Glutamate excitotoxicity in glaucoma: truth or fiction? By AJ Lotery. Eye Jan 27;[Epub ahead of print].
• Osborne NN, Wood J., Muller A. 1995. The influence of experimental ischaemia on protein kinase C and the GABAergic system in the rabbit retina. Neuropharmacology 34:1279—88.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• Ossipov MH, Lai J., Malan TP Jr, Porreca F. 2000, Spinal and supraspinal mechanisms of neuropathic pain. Ann N Y Acad Sci 909:12—24.[Web of Science][Medline] [Order article via Infotrieve]
• Palmer GC 2001. Neuroprotection by NMDA receptor antagonists in a variety of neuropathologies. Curr Drug Targets 2:241—71.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• Paoletti P., Ascher P., Neyton J. 1997, High-affinity zinc inhibition of NMDA NR1-NR2A receptors. J Neurosci 17:5711—25.[Abstract/Free Full Text]
• Paoletti P., Perin-Dureau F., Fayyazuddin A., Le Goff A., Callebaut I., Neyton J. 2000. Molecular organization of a zinc binding n-terminal modulatory domain in a NMDA receptor subunit. Neuron 28:911—25.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• Parsons CG 2001. NMDA receptors as targets for drug action in neuropathic pain. Eur J Pharmacol 429:71—8.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• Parsons CG, Danysz W., Quack G. 1998. Glutamate in CNS disorders as a target for drug development: an update. Drug News Perspect 11:523—69.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• Partin KM, Bowie D., Mayer ML 1995. Structural determinants of allosteric regulation in alternatively spliced AMPA receptors. Neuron 14:833—43.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• Pellegrini-Giampietro DE, Gorter JA, Bennett MV, Zukin RS 1997. The GluR2 (GluR-B) hypothesis: Ca(2+)-permeable AMPA receptors in neurological disorders. Trends Neurosci 20:464—70.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• Perez-Otano I., Schulteis CT, Contractor A., Lipton SA, Trimmer JS, Sucher NJ, and others. 2001. Assembly with the NR1 subunit is required for surface expression of NR3A-containing NMDA receptors. J Neurosci 21:1228—37.[Abstract/Free Full Text]
• Perin-Dureau F., Rachline J., Neyton J., Paoletti P. 2002. Mapping the binding site of the neuroprotectant ifenprodil on NMDA receptors. J Neurosci 22:5955—65.[Abstract/Free Full Text]
• Qian A., Johnson JW 2002. Channel gating of NMDA receptors. Physiol Behav 77:577—82.[CrossRef][Medline] [Order article via Infotrieve]
• Quartaroli M., Carignani C., Dal Forno G, Mugnaini M., Ugolini A., Arban R., and others. 1999. Potent antihyperalgesic activity without tolerance produced by glycine site antagonist of N-methyl-D-aspartate receptor GV196771A. J Pharmacol Exp Ther 290:158—69.[Abstract/Free Full Text]
• Quartaroli M., Fasdelli N., Bettelini L., Maraia G., Corsi M. 2001. GV196771A, an NMDA receptor/glycine site antagonist, attenuates mechanical allodynia in neuropathic rats and reduces tolerance induced by morphine in mice. Eur J Pharmacol 430:219—27.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• Quigley HA 1998. The search for glaucoma genes—implications for pathogenesis and disease detection. N Engl J Med 338:1063—4.[Web of Science][Medline] [Order article via Infotrieve]
• Reisberg, B., Doody, R., Stoffler, A., Schmitt, F., Ferris, S., Mobius, HJ, 2006, A 24-week open-label extension study of memantine in moderate to severe Alzheimer disease, Arch. Neurol., 63: 49-54.[Abstract/Free Full Text]
• Ren Z., Riley NJ, Garcia EP, Sanders JM, Swanson GT, Marshall J. 2003. Multiple trafficking signals regulate kainate receptor KA2 subunit surface expression. J Neurosci 23:6608—16.[Abstract/Free Full Text]
• Sakimura K., Morita T., Kushiya E., Mishina M. 1992. Primary structure and expression of the gamma 2 subunit of the glutamate receptor channel selective for kainate. Neuron 8:267—74.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• Sakurada K., Masu M., Nakanishi S. 1993. Alteration of Ca2+ permeability and sensitivity to Mg2+ and channel blockers by a single amino acid substitution in the N-methyl-D-aspartate receptor. J Biol Chem 268:410—5.[Abstract/Free Full Text]
• Sasaki YF, Rothe T., Premkumar LS, Das S., Cui J., Talantova MV, and others. 2002. Characterization and comparison of the NR3A subunit of the NMDA receptor in recombinant systems and primary cortical neurons. J Neurophysiol 87:2052—63.[Abstract/Free Full Text]
• Sattler R., Xiong Z., Lu WY, Hafner M., MacDonald JF, Tymianski M. 1999. Specific coupling of NMDA receptor activation to nitric oxide neurotoxicity by PSD-95 protein. Science 284:1845—8.[Abstract/Free Full Text]
• Scarpini E., Scheltens P., Feldman H. 2003. Treatment of Alzheimer's disease: current status and new perspectives. Lancet Neurol 2:539—7.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• Schmidt C., Werner M., Hollmann M. 2005. Revisiting the postulated "unitary glutamate receptor": electrophysiological and pharmacological analysis in two heterologous expression systems fails to detect any evidence for its existence. Mol Pharmacol 69:11—29.[Medline] [Order article via Infotrieve]
• Schneggenburger R. 1996. Simultaneous measurement of Ca2+ influx and reversal potentials in recombinant N-methyl-D-aspartate receptor channels. Biophys J 70:2165—74.[Web of Science][Medline] [Order article via Infotrieve]
• Schorge S., Colquhoun D. 2003. Studies of NMDA receptor function and stoichiometry with truncated and tandem subunits. J Neurosci 23:1151—8.[Abstract/Free Full Text]
• Scott DB, Blanpied TA, Swanson GT, Zhang C., Ehlers MD 2001. An NMDA receptor ER retention signal regulated by phosphorylation and alternative splicing. J Neurosci 21:3063—72.[Abstract/Free Full Text]
• Seeber S., Becker K., Rau T., Eschenhagen T., Becker CM, Herkert M. 2000. Transient expression of NMDA receptor subunit NR2B in the developing rat heart. J Neurochem 75:2472—7.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• Seeber S., Humeny A., Herkert M., Rau T., Eschenhagen T., Becker CM 2004. Formation of molecular complexes by N-methyl-D-aspartate receptor subunit NR2B and ryanodine receptor 2 in neonatal rat myocard. J Biol Chem 279:21062—8.[Abstract/Free Full Text]
• Seyfried J., Evert BO, Rundfeldt C., Schulz JB, Kovar KA, Klockgether T., and others. 2000. Flupirtine and retigabine prevent L-glutamate toxicity in rat pheochromocytoma PC 12 cells. Eur J Pharmacol 400:155—66.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• Sheng M., Cummings J., Roldan LA, Jan YN, Jan LY 1994. Changing subunit composition of heteromeric NMDA receptors during development of rat cortex. Nature 368:144—7.[CrossRef][Medline] [Order article via Infotrieve]
• Shleper M., Kartvelishvily E., Wolosker H. 2005. D-serine is the dominant endogenous coagonist for NMDA receptor neurotoxicity in organotypic hippocampal slices. J Neurosci 25:9413—7.[Abstract/Free Full Text]
• Snyder EM, Nong Y., Almeida CG, Paul S., Moran T., Choi EY, and others. 2005. Regulation of NMDA receptor trafficking by amyloidbeta. Nat Neurosci 8:1051—8.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• Snyder SH, Largent BL 1989. Receptor mechanisms in antipsychotic drug action: focus on sigma receptors. J Neuropsychiatry Clin Neurosci 1:7—15.[Medline] [Order article via Infotrieve]
• Sobolevsky AI, Yelshansky MV, Wollmuth LP 2004. The outer pore of the glutamate receptor channel has 2-fold rotational symmetry. Neuron 41:367—78.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• Soloviev MM, Barnard EA 1997. Xenopus oocytes express a unitary glutamate receptor endogenously. J Mol Biol 273:14—8.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• Sommer B., Kohler M., Sprengel R., Seeburg PH 1991. RNA editing in brain controls a determinant of ion flow in glutamate-gated channels. Cell 67:11—9.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• Somogyi P., Eshhar N., Teichberg VI, Roberts JD 1990. Subcellular localization of a putative kainate receptor in Bergmann glial cells using a monoclonal antibody in the chick and fish cerebellar cortex. Neuroscience 35:9—30.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• Standley S., Roche KW, McCallum J., Sans N., Wenthold RJ 2000. PDZ domain suppression of an ER retention signal in NMDA receptor NR1 splice variants. Neuron 28:887—98.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• Stern P., Behe P., Schoepfer R., Colquhoun D. 1992. Single-channel conductances of NMDA receptors expressed from cloned cDNAs: comparison with native receptors. Proc Biol Sci 250:271—7.[CrossRef]
• Sucher NJ, Akbarian S., Chi CL, Leclerc CL, Awobuluyi M., Deitcher DL, and others. 1995. Developmental and regional expression pattern of a novel NMDA receptor-like subunit (NMDAR-L) in the rodent brain. J Neurosci 15:6509—20.[Abstract/Free Full Text]
• Sucher NJ, Lipton SA, Dreyer EB 1997. Molecular basis of glutamate toxicity in retinal ganglion cells. Vision Res 37:3483—93.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• Sullivan JM, Traynelis SF, Chen HS, Escobar W., Heinemann SF, Lipton SA 1994. Identification of two cysteine residues that are required for redox modulation of the NMDA subtype of glutamate receptor. Neuron 13:929—36.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• Sutcliffe MJ, Wo ZG, Oswald RE 1996. Three-dimensional models of non-NMDA glutamate receptors. Biophys J 70:1575—89.[Web of Science][Medline] [Order article via Infotrieve]
• Suzuki Y., Takagi Y., Nakamura R., Hashimoto K., Umemura K. 2003. Ability of NMDA and non-NMDA receptor antagonists to inhibit cerebral ischemic damage in aged rats. Brain Res 964:116—20.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• Tang LH, Aizenman E. 1993. Allosteric modulation of the NMDA receptor by dihydrolipoic and lipoic acid in rat cortical neurons in vitro. Neuron 11:857—63.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• Temkin NR, Jarell AD, Anderson GD 2001. Antiepileptogenic agents: how close are we? Drugs 61:1045—55.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• Tichelaar W., Safferling M., Keinanen K., Stark H., Madden DR 2004. The three-dimensional structure of an ionotropic glutamate receptor reveals a dimer-of-dimers assembly. J Mol Biol 344:435—42.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• Traynelis SF, Cull-Candy SG 1990. Proton inhibition of N-methyl-D-aspartate receptors in cerebellar neurons. Nature 345:347—50.[CrossRef][Medline] [Order article via Infotrieve]
• Traynelis SF, Hartley M., Heinemann SF 1995. Control of proton sensitivity of the NMDA receptor by RNA splicing and polyamines. Science 268:873—6.[Abstract/Free Full Text]
• Tsai G., Lane HY, Yang P., Chong MY, Lange N. 2004. Glycine transporter I inhibitor, N-methylglycine (sarcosine), added to antipsychotics for the treatment of schizophrenia. Biol Psychiatry 55:452—6.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• Villmann C., Bull L., Hollmann M. 1997. Kainate binding proteins possess functional ion channel domains. J Neurosci 17:7634—43.[Abstract/Free Full Text]
• Villmann C., Strutz N., Morth T., Hollmann M. 1999. Investigation by ion channel domain transplantation of rat glutamate receptor subunits, orphan receptors and a putative NMDA receptor subunit. Eur J Neurosci 11:1765—78.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• Waibel S., Reuter A., Malessa S., Blaugrund E., Ludolph AC 2004. Rasagiline alone and in combination with riluzole prolongs survival in an ALS mouse model. J Neurol 251:1080—4.[Web of Science][Medline] [Order article via Infotrieve]
• Wainai T., Takeuchi T., Seo N., Mishina M. 2001. Regulation of acute nociceptive responses by the NMDA receptor GluRepsilon2 subunit. Neuroreport 12:3169—72.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• Wallace MS, Rowbotham MC, Katz NP, Dworkin RH, Dotson RM, Galer BS, and others. 2002. A randomized, double-blind, placebo-controlled trial of a glycine antagonist in neuropathic pain. Neurology 59:1694—1700.[Abstract/Free Full Text]
• Weber M., Bonaventure N., Sahel JA 1995. Protective role of excitatory amino acid antagonists in experimental retinal ischemia. Graefes Arch Clin Exp Ophthalmol 233:360—5.[Web of Science][Medline] [Order article via Infotrieve]
• Wei F., Wang GD, Kerchner GA, Kim SJ, Xu HM, Chen ZF, and others. 2001. Genetic enhancement of inflammatory pain by forebrain NR2B overexpression. Nat Neurosci 4:164—9.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• Williams K. 1993. Ifenprodil discriminates subtypes of the N-methyl-D-aspartate receptor: selectivity and mechanisms at recombinant heteromeric receptors. Mol Pharmacol 44:851—9.[Abstract]
• Williams K. 1997. Interactions of polyamines with ion channels. Biochem J 325(Pt 2):289—97.[Web of Science][Medline] [Order article via Infotrieve]
• Winterer G., Weinberger DR 2004. Genes, dopamine and cortical signal-to-noise ratio in schizophrenia. Trends Neurosci 27:683—90.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• Wo ZG, Oswald RE 1995a. A topological analysis of goldfish kainate receptors predicts three transmembrane segments. J Biol Chem 270:2000—9.[Abstract/Free Full Text]
• Wo ZG, Oswald RE 1995b. Unraveling the modular design of glutamate-gated ion channels. Trends Neurosci 18:161—8.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• Wollmuth LP, Kuner T., Jatzke C., Seeburg PH, Heintz N., Zuo J. 2000. The Lurcher mutation identifies delta 2 as an AMPA/kainate receptor-like channel that is potentiated by Ca(2+). J Neurosci 20: 5973—80.[Abstract/Free Full Text]
• Wollmuth LP, Sobolevsky AI 2004. Structure and gating of the glutamate receptor ion channel. Trends Neurosci 27:321—8.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• Wong CS, Wu CT, Yu JC, Yeh CC, Lee MM, Tao PL 1999. Preincisional dextromethorphan decreases postoperative pain and opioid requirement after modified radical mastectomy. Can J Anaesth 46:1122—6.[Web of Science][Medline] [Order article via Infotrieve]
• Wood PL 2005. The NMDA receptor complex: a long and winding road to therapeutics. IDrugs 8:229—35.[Web of Science][Medline] [Order article via Infotrieve]
• Wood PL, Hawkinson JE 1997. N-methyl-D-aspartate antagonists for stroke and head trauma. Expert Opin Investig Drugs 6:389—97.[CrossRef][Medline] [Order article via Infotrieve]
• Woodward JJ 2000. Ethanol and NMDA receptor signaling. Crit Rev Neurobiol 14:69—89.[Web of Science][Medline] [Order article via Infotrieve]
• Wyszynski M., Lin J., Rao A., Nigh E., Beggs AH, Craig AM, and others. 1997. Competitive binding of alpha-actinin and calmodulin to the NMDA receptor. Nature 385:439—42.[CrossRef][Medline] [Order article via Infotrieve]
• Yuzaki M. 2004. The delta2 glutamate receptor: a key molecule controlling synaptic plasticity and structure in Purkinje cells. Cerebellum 3:89—93.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• Zerangue N., Schwappach B., Jan YN, Jan LY 1999. A new ER trafficking signal regulates the subunit stoichiometry of plasma membrane K(ATP) channels. Neuron 22:537—48.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• Zhang L., Hsu JC, Takagi N., Gurd JW, Wallace MC, Eubanks JH 1997. Transient global ischemia alters NMDA receptor expression in rat hippocampus: correlation with decreased immunoreactive protein levels of the NR2A/2B subunits, and an altered NMDA receptor functionality. J Neurochem 69:1983—94.[Web of Science][Medline] [Order article via Infotrieve]
• Zheng F., Erreger K., Low CM, Banke T., Lee CJ, Conn PJ, and others. 2001. Allosteric interaction between the amino terminal domain and the ligand binding domain of NR2A. Nat Neurosci 4:894—901.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• Zhu Y., Auerbach A. 2001. K(+) occupancy of the N-methyl-D-aspartate receptor channel probed by Mg(2+) block. J Gen Physiol 117:287—98.[Abstract/Free Full Text]
• Zuo J., De Jager PL, Takahashi KA, Jiang W., Linden DJ, Heintz N. 1997. Neurodegeneration in Lurcher mice caused by mutation in delta2 glutamate receptor gene. Nature 388:769—73.[CrossRef][Medline] [Order article via Infotrieve]

This version was published on December 1, 2007

The Neuroscientist, Vol. 13, No. 6, 594-615 (2007)
DOI: 10.1177/1073858406296259


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?

This article has been cited by other articles:

				C. Beste, C. Saft, O. Gunturkun, and M. Falkenstein Increased Cognitive Functioning in Symptomatic Huntington's Disease As Revealed by Behavioral and Event-Related Potential Indices of Auditory Sensory Memory and Attention J. Neurosci., November 5, 2008; 28(45): 11695 - 11702. [Abstract] [Full Text] [PDF]

				D. M. Hermann Review: Future perspectives for brain pharmacotherapies: implications of drug transport processes at the blood--brain barrier Therapeutic Advances in Neurological Disorders, November 1, 2008; 1(3): 167 - 179. [Abstract] [PDF]

				A. D. Steele All quiet on the neuronal front: NMDA receptor inhibition by prion protein J. Cell Biol., October 14, 2008; 181(3): 407 - 409. [Abstract] [Full Text] [PDF]

				S. Ellefsen, G. K. Sandvik, H. K. Larsen, K.-O. Stenslokken, D. A. S. Hov, T. A. Kristensen, and G. E. Nilsson Expression of genes involved in excitatory neurotransmission in anoxic crucian carp (Carassius carassius) brain Physiol Genomics, September 17, 2008; 35(1): 5 - 17. [Abstract] [Full Text] [PDF]

This Article Abstract Free Full Text (Free PDF) Free Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in Web of Science Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via HighWire Citing Articles via Web of Science (10) Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Villmann, C. Articles by Becker, C.-M. Search for Related Content PubMed PubMed Citation Articles by Villmann, C. Articles by Becker, C.-M. Pubmed/NCBI databases Medline Plus Health Information Degenerative Nerve Diseases Social Bookmarking                         What's this?